| - GRCh37:
- Chr11:58916346-64972349
| CAPN1, DDB1, MS4A10, SYT7, FADS1, FEN1, MIR192, ASRGL1, TM7SF2, SNORD22, LRRC10B, SCGB2A1, TAF6L, SLC22A10, CYB561A3, SPDYC, CD5, TRPT1, CCDC88B, MS4A14, TMEM109, ZBTB3, LRRN4CL, POLR2G, TMEM138, ZFTA, TMEM132A, MS4A12, SNORD29, OR4D10, OR5A2, UQCC3, MARK2, SLC15A3, TRMT112, SLC22A9, OTUB1, FTH1, SLC22A11, MS4A3, EEF1G, CSKMT, FKBP2, RTN3, SLC3A2, SCGB1D1, LBHD1, PLAAT5, CDCA5, SLC22A24, MS4A6A, OOSP2, TMEM179B, FAU, MAP4K2, STX3, SNORD31, SNORD30, EHD1, KCNK4, AHNAK, PRDX5, SNORD26, MS4A13, PYGM, DNAJC4, NRXN2, ZFPL1, MS4A8, TKFC, BEST1, SLC22A6, OR4D11, MIR194-2, TMEM223, PLCB3, VPS37C, MEN1, MS4A6E, SLC22A25, INCENP, SNHG1, ATG2A, OR10V1, NAA40, ESRRA, GANAB, OR4D6, LGALS12, BSCL2, SCGB1A1, PLAAT4, RPS6KA4, VEGFB, RAB3IL1, PPP1R14B, FERMT3, HNRNPUL2, PPP1R32, PGA5, BAD, GPHA2, ARL2, ZNHIT2, BATF2, B3GAT3, NUDT22, WDR74, NXF1, FLRT1, MS4A2, DTX4, STX5, GPR137, MS4A7, PATL1, PTGDR2, DAGLA, MS4A18, CDC42BPG, PPP2R5B, MS4A15, SDHAF2, MTA2, MS4A4E, OSBP, SAC3D1, MS4A5, MPEG1, PLAAT3, RCOR2, INTS5, FAM111A, EML3, ROM1, TTC9C, VPS51, GNG3, OR4D9, PRPF19, SPINDOC, CD6, SLC22A12, CBLIF, CCDC86, SCGB1D4, CHRM1, MS4A1, TMEM258, ATL3, PLAAT2, SYVN1, TMEM216, PGA4, COX8A, FADS2, SNX15, CATSPERZ, MS4A4A, SNORD28, SCGB1D2, SF1, MAJIN, CPSF7, OR5AN1, MACROD1, FADS3, STIP1, TUT1, MRPL49, UBXN1, MYRF, SLC22A8, VWCE, MRPL16, ZP1, SNORD27, TCN1, RASGRP2, NAALADL1, SNORD25, SCGB2A2, OR5A1, PGA3 | | not provided, Leukocyte adhesion deficiency 3 | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63986850
- GRCh38:
- Chr11:64219378
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990574
- GRCh38:
- Chr11:64223102
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990829
- GRCh38:
- Chr11:64223357
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987259
- GRCh38:
- Chr11:64219787
| FERMT3 | F359L, F179L | Leukocyte adhesion deficiency 3, Inborn genetic diseases | Uncertain significance (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:63990656
- GRCh38:
- Chr11:64223184
| FERMT3 | R427W, R603W, R423W, R607W | Leukocyte adhesion deficiency 3 | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987988
- GRCh38:
- Chr11:64220516
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990949
- GRCh38:
- Chr11:64223477
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990567
- GRCh38:
- Chr11:64223095
| FERMT3 | R397Q, R573Q, R577Q, R393Q | Leukocyte adhesion deficiency 3, Inborn genetic diseases | Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:63978335
- GRCh38:
- Chr11:64210863
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974960
- GRCh38:
- Chr11:64207488
| FERMT3 | I42V | Leukocyte adhesion deficiency 3 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987065
- GRCh38:
- Chr11:64219593
| FERMT3 | D142N, D322N | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988631
- GRCh38:
- Chr11:64221159
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990880
- GRCh38:
- Chr11:64223408
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990859
- GRCh38:
- Chr11:64223387
| FERMT3 | E629D, E449D, E453D, E633D | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974881
- GRCh38:
- Chr11:64207409
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978663
- GRCh38:
- Chr11:64211191
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988079
- GRCh38:
- Chr11:64220607
| FERMT3 | E499K, E315K, E319K, E495K | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990589
- GRCh38:
- Chr11:64223117
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979237
- GRCh38:
- Chr11:64211765
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978549
- GRCh38:
- Chr11:64211077
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978086
- GRCh38:
- Chr11:64210614
| FERMT3 | R55H | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988538
- GRCh38:
- Chr11:64221066
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987347
- GRCh38:
- Chr11:64219875
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987136
- GRCh38:
- Chr11:64219664
| FERMT3 | | Leukocyte adhesion deficiency 3 | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988155
- GRCh38:
- Chr11:64220683
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990861
- GRCh38:
- Chr11:64223389
| FERMT3 | Y630C, Y454C, Y450C, Y634C | Leukocyte adhesion deficiency 3 | Uncertain significance (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974991
- GRCh38:
- Chr11:64207519
| FERMT3 | Q52R | Leukocyte adhesion deficiency 3 | Uncertain significance (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978273
- GRCh38:
- Chr11:64210801
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990885
- GRCh38:
- Chr11:64223413
| FERMT3 | S458*, S462*, S642*, S638* | Leukocyte adhesion deficiency 3 | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63986770
- GRCh38:
- Chr11:64219298
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974943
- GRCh38:
- Chr11:64207471
| FERMT3 | V36A | Leukocyte adhesion deficiency 3 | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987956
- GRCh38:
- Chr11:64220484
| FERMT3 | G274S, G278S, G458S, G454S | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978737
- GRCh38:
- Chr11:64211265
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988044
- GRCh38:
- Chr11:64220572
| FERMT3 | P303R, P307R, P487R, P483R | Leukocyte adhesion deficiency 3 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974882
- GRCh38:
- Chr11:64207410
| FERMT3 | W16R | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987485
- GRCh38:
- Chr11:64220013
| FERMT3 | K225T, K405T, K221T, K401T | Leukocyte adhesion deficiency 3 | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990866
- GRCh38:
- Chr11:64223394
| FERMT3 | G452R, G632R, G456R, G636R | Leukocyte adhesion deficiency 3 | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987196
- GRCh38:
- Chr11:64219724
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988508
- GRCh38:
- Chr11:64221036
| FERMT3 | E522D, E342D, E526D, E346D | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978776
- GRCh38:
- Chr11:64211304
| FERMT3 | P182S, P2S | Leukocyte adhesion deficiency 3 | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978327
- GRCh38:
- Chr11:64210855
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988554
- GRCh38:
- Chr11:64221082
| FERMT3 | R538C, R358C, R542C, R362C | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978875
- GRCh38:
- Chr11:64211403
| FERMT3 | R35W, R215W | Leukocyte adhesion deficiency 3 | Uncertain significance (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979116
- GRCh38:
- Chr11:64211644
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987031
- GRCh38:
- Chr11:64219559
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978245
- GRCh38:
- Chr11:64210773
| FERMT3 | R108H | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987447
- GRCh38:
- Chr11:64219975
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978063
- GRCh38:
- Chr11:64210591
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978851
- GRCh38:
- Chr11:64211379
| FERMT3 | P207A, P27A | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63986782-63986788
- GRCh38:
- Chr11:64219310-64219316
| FERMT3 | E103fs, E283fs | Leukocyte adhesion deficiency 3 | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990674
- GRCh38:
- Chr11:64223202
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990550
- GRCh38:
- Chr11:64223078
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987804
- GRCh38:
- Chr11:64220332
| FERMT3 | | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990879
- GRCh38:
- Chr11:64223407
| FERMT3 | F636Y, F640Y, F460Y, F456Y | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63986779
- GRCh38:
- Chr11:64219307
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990615
- GRCh38:
- Chr11:64223143
| FERMT3 | R413L, R589L, R593L, R409L | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988576
- GRCh38:
- Chr11:64221104
| FERMT3 | S369F, S545F, S549F, S365F | Leukocyte adhesion deficiency 3 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978573
- GRCh38:
- Chr11:64211101
| FERMT3 | K148N | Leukocyte adhesion deficiency 3 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979170
- GRCh38:
- Chr11:64211698
| FERMT3 | A66V, A246V | Leukocyte adhesion deficiency 3 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979182
- GRCh38:
- Chr11:64211710
| FERMT3 | R70L, R250L | Leukocyte adhesion deficiency 3 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987948
- GRCh38:
- Chr11:64220476
| FERMT3 | A271G, A275G, A451G, A455G | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988108
- GRCh38:
- Chr11:64220636
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987470
- GRCh38:
- Chr11:64219998
| FERMT3 | Q396R, Q220R, Q216R, Q400R | Leukocyte adhesion deficiency 3 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987709
- GRCh38:
- Chr11:64220237
| FERMT3 | D408N, D228N, D412N, D232N | Leukocyte adhesion deficiency 3 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990889-63990890
- GRCh38:
- Chr11:64223417-64223418
| FERMT3 | R464G, R640G, R460G, R644G | Leukocyte adhesion deficiency 3 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978135
- GRCh38:
- Chr11:64210663
| FERMT3 | Q71H | Leukocyte adhesion deficiency 3 | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978560
- GRCh38:
- Chr11:64211088
| FERMT3 | A144G | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987112
- GRCh38:
- Chr11:64219640
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979182
- GRCh38:
- Chr11:64211710
| FERMT3 | R250H, R70H | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987411
- GRCh38:
- Chr11:64219939
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987252
- GRCh38:
- Chr11:64219780
| FERMT3 | R177Q, R357Q | Leukocyte adhesion deficiency 3 | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978841
- GRCh38:
- Chr11:64211369
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987453
- GRCh38:
- Chr11:64219981
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990951
- GRCh38:
- Chr11:64223479
| FERMT3 | H484R, H480R, H660R, H664R | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978235
- GRCh38:
- Chr11:64210763
| FERMT3 | P105S | Leukocyte adhesion deficiency 3 | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990581
- GRCh38:
- Chr11:64223109
| FERMT3 | D402N, D582N, D398N, D578N | Leukocyte adhesion deficiency 3 | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987141
- GRCh38:
- Chr11:64219669
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987085
- GRCh38:
- Chr11:64219613
| FERMT3 | S148R, S328R | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978766
- GRCh38:
- Chr11:64211294
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63990785
- GRCh38:
- Chr11:64223313
| FERMT3 | V429M, V609M, V425M, V605M | Leukocyte adhesion deficiency 3 | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987689
- GRCh38:
- Chr11:64220217
| FERMT3 | | Leukocyte adhesion deficiency 3 | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979181
- GRCh38:
- Chr11:64211709
| FERMT3 | R70C, R250C | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63974838
- GRCh38:
- Chr11:64207366
| FERMT3 | M1R | Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63986839
- GRCh38:
- Chr11:64219367
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979133
- GRCh38:
- Chr11:64211661
| FERMT3 | R234W, R54W | Leukocyte adhesion deficiency 3 | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978658
- GRCh38:
- Chr11:64211186
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979163
- GRCh38:
- Chr11:64211691
| FERMT3 | G244R, G64R | Leukocyte adhesion deficiency 3 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987150
- GRCh38:
- Chr11:64219678
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978825
- GRCh38:
- Chr11:64211353
| FERMT3 | L18P, L198P | Leukocyte adhesion deficiency 3 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr11:63988555
- GRCh38:
- Chr11:64221083
| FERMT3 | R358H, R362H, R538H, R542H | not provided, Leukocyte adhesion deficiency 3 | Uncertain significance (Mar 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:63987022
- GRCh38:
- Chr11:64219550
| FERMT3 | S127fs, S307fs | Leukocyte adhesion deficiency 3 | Pathogenic (May 5, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr11:63978874
- GRCh38:
- Chr11:64211402
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63979135
- GRCh38:
- Chr11:64211663
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jan 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978564
- GRCh38:
- Chr11:64211092
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987348
- GRCh38:
- Chr11:64219876
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63978141
- GRCh38:
- Chr11:64210669
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (May 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987970
- GRCh38:
- Chr11:64220498
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Jul 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63975007
- GRCh38:
- Chr11:64207535
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:63987985
- GRCh38:
- Chr11:64220513
| FERMT3 | | Leukocyte adhesion deficiency 3 | Likely benign (Dec 15, 2020) | criteria provided, single submitter |